Company / Operating Income per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.93
FY2025
5-year range
-$2.01 / $1.93
FY2021-FY2025
Trend
+806.2%
vs FY2024
Sector context
#31 of 201
Health Care
What the data says
Operating Income per Share changed +806% YoY in FY2025, a notable deviation from the 9-year average annual change of -1099848%.
Based on SEC 10-K filings.
1.93 in FY2025. Top quartile in the Health Care sector.
Improved from $0.39 to $1.93 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 201This company $1.93 Sector average -$3.23
▼
+159.6% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 806.2% year-over-year.
- Ranks #31 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.93 | +806.2% |
| FY2024 | -$0.27 | -169.8% |
| FY2023 | $0.39 | +119.5% |
| FY2022 | -$2.01 | -227.6% |
| FY2021 | $1.57 | +145.0% |
| FY2020 | -$3.50 | -702.4% |
| FY2019 | -$0.44 | +100.0% |
| FY2018 | -$1703433.92 | -9898600.9% |
| FY2017 | -$17.21 | -100.0% |
| FY2016 | $2241415.19 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026